Paul Fischer, MD
Plastic Surgery · Milford, CTNPI 1366486078
Payments from drug & device makers
What this record shows
34 manufacturers reported payments, led by AbbVie at 54.2% of the total. Reporting peaked in 2019 at $3,561 and has fallen 91.0% since, to $320 in 2025.
Across 145 payments — averaging $40.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Lilly USA, LLC$449
- Merz North America, Inc.$442
- Novo Nordisk$362
- Sanofi$196
- Regeneron Healthcare Solutions, Inc.$128
- plus $1K from 28 others
What the payments were for
- Food & beverage$3,24055%
- Gifts$2,70045%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 24 | $3,218 |
| Lilly USA, LLC | 20 | $449 |
| Merz North America, Inc. | 3 | $442 |
| Novo Nordisk | 21 | $362 |
| Sanofi | 9 | $196 |
| Regeneron Healthcare Solutions, Inc. | 7 | $128 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $117 |
| Incyte Corporation | 5 | $115 |
| Johnson & Johnson(2 entities) | 4 | $85 |
| LEO Pharma Inc. | 5 | $84 |
| Amgen | 4 | $83 |
| Merck | 4 | $56 |
| Sun Pharmaceutical Industries Inc. | 3 | $54 |
| Almirall LLC | 3 | $48 |
| Insulet Corporation | 3 | $45 |
| Revance Therapeutics, Inc. | 2 | $43 |
| Galderma Laboratories, L.p. | 2 | $40 |
| Corcept Therapeutics | 2 | $35 |
| Valeritas, Inc. | 1 | $35 |
| Amarin Pharma, Inc. | 2 | $34 |
| Mission Pharmacal Company | 2 | $28 |
| Medtronic | 1 | $26 |
| Amneal Pharmaceuticals LLC | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $20 |
| Boston Scientific | 1 | $20 |
| Companion Medical, Inc. | 1 | $18 |
| Biofrontera Inc. | 1 | $17 |
| Vivus LLC | 1 | $16 |
| Acelrx Pharmaceuticals, Inc. | 1 | $15 |
| Mentor Worldwide LLC | 1 | $14 |
| Shire North American Group Inc | 1 | $14 |
| Mayne Pharma Commercial LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE$2,700
How this compares
$5,940 in reported general payments places this provider in the 80th percentile of 62 plastic surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic surgery in Milford
- Michael AlperovichNew Haven$78K
- Derek SteinbacherGuilford$59K
- Siba HaykalNew Haven$45K
- Wilfred BrownMiddlebury$34K
- Beth CollinsGuilford$29K
- Stephen BrownHartford$17K
- Gary RussolilloWest Hartford$15K
- Melissa MastroianniFairfield$14K
- Patrick FeliceBloomfield$13K
- Leif NordbergStamford$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.